News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Molecular Targeting Technologies, Inc. Licenses Cell Targeting Technology from the Molecular Targeting Technologies, Inc.
March 1, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc., (MTTI) announced that it has obtained an exclusive license from the University of Notre Dame for novel sensing technology developed by Professor Bradley Smith.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
University of Notre Dame
MORE ON THIS TOPIC
Earnings
Novo Goes ‘All In’ on Wegovy Pill but Analysts Worry It’s Not Enough
February 4, 2026
·
3 min read
·
Annalee Armstrong
Earnings
Amgen Wants MariTide To Change Obesity Paradigm With Longer Dosing Periods
February 4, 2026
·
2 min read
·
Tristan Manalac
Earnings
GSK Says No to GLP-1s, Prioritizes ‘Downstream Effects’ of Obesity
February 4, 2026
·
2 min read
·
Tristan Manalac
Earnings
Lilly’s GLP-1s Mounjaro, Zepbound Push Revenue up 46% in Q4
February 4, 2026
·
1 min read
·
Annalee Armstrong